Lexington, MA, United States of America

Thomas Andrew Wynn

USPTO Granted Patents = 30 

 

 

Average Co-Inventor Count = 4.5

ph-index = 8

Forward Citations = 207(Granted Patents)


Company Filing History:


Years Active: 2014-2025

Loading Chart...
Loading Chart...
Loading Chart...
30 patents (USPTO):

Title: Thomas Andrew Wynn: A Pioneer in Pharmaceutical Innovations

Introduction

Thomas Andrew Wynn, based in Lexington, MA, is a notable inventor with a significant contribution to the field of pharmaceuticals. With a remarkable portfolio of 29 patents, Wynn has been instrumental in the development of innovative treatments aimed at addressing various neurological diseases.

Latest Patents

Among his latest inventions are two related patents titled "Prodrugs of Fumarates and Their Use in Treating Various Diseases." These patents detail compounds of formula (I) and their corresponding pharmaceutical compositions. The inventions provide vital methods for treating neurological diseases, particularly multiple sclerosis, showcasing Wynn’s commitment to advancing medical science.

Career Highlights

Throughout his impressive career, Wynn has collaborated with prominent companies in the pharmaceutical sector, including Alkermes Pharma Ireland Limited and Alkermes, Inc. His work at these institutions has enabled the translation of innovative research into viable therapeutic solutions.

Collaborations

Wynn has had the privilege of working alongside esteemed colleagues in his field, including Christopher P. Hencken and Carlos N. Sanrame. These collaborations have fostered a rich environment for creativity and innovation, driving forward the development of cutting-edge treatments.

Conclusion

In summary, Thomas Andrew Wynn stands out as a significant figure in the realm of pharmaceutical innovations. His extensive patent portfolio and collaborations reflect his dedication to improving healthcare outcomes through inventive solutions. As ongoing research continues to evolve, Wynn’s contributions will undoubtedly play a vital role in shaping the future of treatments for neurological diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…